Literature DB >> 14610481

Systemic responsiveness to lipopolysaccharide and polymorphisms in the toll-like receptor 4 gene in human beings.

Olivier Michel1, Tricia D LeVan, Debbie Stern, Mieke Dentener, Jörgen Thorn, Daniele Gnat, M Lena Beijer, Pascale Cochaux, Patrick G Holt, Fernando D Martinez, Ragnar Rylander.   

Abstract

BACKGROUND: The response to lipopolysaccharide exposure is highly variable and might be a result of genetic diversity between individuals. The toll-like receptor 4 (TLR-4) is the principal receptor for lipopolysacharide.
OBJECTIVES: We investigated the association between single-nucleotide polymorphisms in the TLR4 locus and levels of systemic inflammatory markers in response to lipopolysaccharide.
METHODS: Healthy subjects (n = 116) were genotyped for the most frequent polymorphisms found in the promoter and coding region of the TLR4 gene (-2026A/T, -1607T/C, +896A/G, and +1196C/T relative to the translation start site). Subjects were challenged with 20 microg lipopolysaccharide by inhalation.
RESULTS: Polymorphisms at +896 and +1196 were in complete linkage disequilibrium, and no homozygotes for the less common allele, G and T respectively, were found. After lipopolysaccharide inhalation, subjects heterozygous for either TLR-4/+896 or TLR4/+1196 had significantly lower numbers of white blood cell counts and lower levels of C-reactive protein and lipopolysaccharide-binding protein compared with homozygotes with the common allele. None of the heterozygous subjects (n = 18) except 1 were high responders to lipopolysaccharide (defined as a rise in C-reactive protein > 10 mg/L), whereas 36 of 98 homozygous subjects were high responders (P <.02). No association was observed between the TLR-4/-2026 and TLR-4/-1607 polymorphisms and lipopolysaccharide responsiveness.
CONCLUSION: The single-nucleotide polymorphisms at position +896 or +1196 in the TLR-4 gene is associated with systemic inflammatory hyporesponsiveness to inhaled lipopolysaccharide.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14610481     DOI: 10.1016/j.jaci.2003.05.001

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  33 in total

1.  Multivariate analysis of cytokine responses identifies distinctive sensitivities to lipopolysaccharide in humans.

Authors:  David D Duncan; Lorrie Tiberio; John H Eldridge
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

Review 2.  TLR4 polymorphisms and disease susceptibility.

Authors:  Mamoona Noreen; Muhammad Ali A Shah; Sheeba Murad Mall; Shazia Choudhary; Tahir Hussain; Iltaf Ahmed; Syed Fazal Jalil; Muhammad Imran Raza
Journal:  Inflamm Res       Date:  2012-01-26       Impact factor: 4.575

Review 3.  Into the eye of the cytokine storm.

Authors:  Jennifer R Tisoncik; Marcus J Korth; Cameron P Simmons; Jeremy Farrar; Thomas R Martin; Michael G Katze
Journal:  Microbiol Mol Biol Rev       Date:  2012-03       Impact factor: 11.056

4.  Association between variants in genes involved in the immune response and prostate cancer risk in men randomized to the finasteride arm in the Prostate Cancer Prevention Trial.

Authors:  Danyelle A Winchester; Cathee Till; Phyllis J Goodman; Catherine M Tangen; Regina M Santella; Teresa L Johnson-Pais; Robin J Leach; Jianfeng Xu; S Lilly Zheng; Ian M Thompson; M Scott Lucia; Scott M Lippman; Howard L Parnes; William B Isaacs; Angelo M De Marzo; Charles G Drake; Elizabeth A Platz
Journal:  Prostate       Date:  2017-03-20       Impact factor: 4.104

5.  Mutations in lipopolysaccharide-binding protein (LBP) gene change the susceptibility to clinical mastitis in Chinese Holstein.

Authors:  Jienan Cheng; Jun Li; Wenxin Zhang; Yafei Cai; Genlin Wang
Journal:  Mol Biol Rep       Date:  2012-06-26       Impact factor: 2.316

6.  Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation.

Authors:  Bernd Krüger; Stefanie Krick; Navdeep Dhillon; Susan M Lerner; Scott Ames; Jonathan S Bromberg; Marvin Lin; Liron Walsh; John Vella; Michael Fischereder; Bernhard K Krämer; Robert B Colvin; Peter S Heeger; Barbara T Murphy; Bernd Schröppel
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-13       Impact factor: 11.205

7.  Toll-like receptor 4 promoter polymorphisms: common TLR4 variants may protect against severe urinary tract infection.

Authors:  Bryndís Ragnarsdóttir; Klas Jönsson; Alexander Urbano; Jenny Grönberg-Hernandez; Nataliya Lutay; Martti Tammi; Mattias Gustafsson; Ann-Charlotte Lundstedt; Irene Leijonhufvud; Diana Karpman; Björn Wullt; Lennart Truedsson; Ulf Jodal; Björn Andersson; Catharina Svanborg
Journal:  PLoS One       Date:  2010-05-20       Impact factor: 3.240

8.  TLR4 Asp299Gly and Thr399Ile polymorphisms: no impact on human immune responsiveness to LPS or respiratory syncytial virus.

Authors:  Renée N Douville; Yuriy Lissitsyn; Aaron F Hirschfeld; Allan B Becker; Anita L Kozyrskyj; Joel Liem; Nathalie Bastien; Yan Li; Rachel E Victor; Mehtab Sekhon; Stuart E Turvey; Kent T HayGlass
Journal:  PLoS One       Date:  2010-08-10       Impact factor: 3.240

9.  Lipopolysaccharide-induced immune responses in relation to the TLR4(Asp299Gly) gene polymorphism.

Authors:  Anna Lundberg; Lars Andersson Wikberg; Jorma Ilonen; Outi Vaarala; Malin Fagerås Böttcher
Journal:  Clin Vaccine Immunol       Date:  2008-10-15

10.  Association of the TLR4 Asp299Gly polymorphism with lung function in relation to body mass index.

Authors:  Punam Pahwa; Chandima P Karunanayake; Donna C Rennie; Yue Chen; David A Schwartz; James A Dosman
Journal:  BMC Pulm Med       Date:  2009-09-21       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.